…
Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
…
Glucose Variability
…
Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38: Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic…
…
A Genome-Wide Association Study Identifies GRK5 and RASGRP1 as Type 2 Diabetes Loci in Chinese Hans
…
Air Pollution and Type 2 Diabetes: Mechanistic Insights
…
A Fully Human, Allosteric Monoclonal Antibody That Activates the Insulin Receptor and Improves Glycemic Control
…
Liver X Receptor alpha Is Involved in the Transcriptional Regulation of the 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase Gene
…
The ACCORD (Action to Control Cardiovascular Risk in Diabetes) Lipid Trial: What we learn from subgroup analyses
…
miR-200a Prevents Renal Fibrogenesis Through Repression of TGF-beta2 Expression
…
